Selective serotonin reuptake inhibitors and intraoperative blood pressure

American Journal of Hypertension

Volumn 25, Issue 2, 2012, Pages 223-228

  Van Haelst, Ingrid M M ^a,b   Van Klei, Wilton A ^b   Doodeman, Hieronymus J ^a   Kalkman, Cor J ^b   Egberts, Toine C G ^b,c  

^a Location Alkmaar   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

blood pressure; hypertension; intraoperative; selective serotonin reuptake inhibitors; side effects

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CITALOPRAM; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DISEASE DURATION; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPOTENSION; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 84856049523     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.194     Document Type: Article

References (36)

1. Gartlehner G, Hansen RA, Thieda P, DeVaugh-geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN. Comparative effectiveness of second-generation antidepressants in the pharmacological treatment of adult depression. Comparative effectiveness review No.7-EHC007-EF. Agency for Health research and Qualtity: MD . Accessed 16 May 2011
2. Martin RM, Hilton SR, Kerry SM, Richards NM. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. BMJ 1997; 314:646-651. (Pubitemid 27099882)
3. Rosholm JU, Andersen M, Gram LF. Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 2001; 56:923-929. (Pubitemid 33788571)
4. Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK; Clinical Efficacy Assessment Subcommittee of American College of Physicians. Using secondgeneration antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 149:725-733.
5. Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van Dyck R, Penninx BW. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009; 53:631-638.
6. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998; 59: 502-508. (Pubitemid 28492413)
7. Thase ME, Tran PV, Wiltse C, Pangallo BA, Mallinckrodt C, Detke MJ. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharmacol 2005; 25:132-140. (Pubitemid 40395091)
8. Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Beasley C. Blood pressure changes during short-term fluoxetine treatment. J Clin Psychopharmacol 1999; 19:9-14. (Pubitemid 29047325)
9. Grubb BP, Kosinski DJ. Serotonin and syncope: an emerging connection? Eur J Cardiac Pacing Electrophysiol 1995; 5:306-314. (Pubitemid 26104577)
10. Grubb BP, Samoil D, Kosinski D, Wolfe D, Lorton M, Madu E. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med 1994; 97:366-368. (Pubitemid 24313097)
11. Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernández- Díaz S. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry 2009; 166:320-328.
12. Polyàk J. How should we manage cardiovascular panic disorders accompanied by hypertension? J Hypertension 2001; 19:S64
13. Davies SJ, Hood SD, Argyropoulos SV, Morris K, Bell C, Witchel HJ, Jackson PR, Nutt DJ, Potokar JP. Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J Clin Psychopharmacol 2006; 26:414-418. (Pubitemid 44187646)
14. Davies SJ, Lowry CA, Nutt DJ. Panic and hypertension: brothers in arms through 5-HT? J Psychopharmacol (Oxford) 2007; 21:563-566. (Pubitemid 47472728)
15. Finkel MS, Laghrissi-Thode F, Pollock BG, Rong J. Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull 1996; 32:653-658. (Pubitemid 26428269)
16. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996; 37:12-16. (Pubitemid 26021814)
17. Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KG, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology 2007; 107:213-220. (Pubitemid 47196483)
18. Bijker JB, van Klei WA, Vergouwe Y, Eleveld DJ, van Wolfswinkel L, Moons KG, Kalkman CJ. Intraoperative hypotension and 1-year mortality after noncardiac surgery. Anesthesiology 2009; 111:1217-1226.
19. Reich DL, Bennett-Guerrero E, Bodian CA, Hossain S, Winfree W, Krol M. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg 2002; 95:273-7, table of contents. (Pubitemid 34793082)
20. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 2005; 100:4-10. (Pubitemid 40013594)
21. World Health Organization collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification . Accessed 20 May 2011.
22. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006; 63:283-288. (Pubitemid 43345352)
23. Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P. A doubleblind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003; 44:216-221. (Pubitemid 36514728)
24. van Melle JP, de Jonge P, van den Berg MP, Pot HJ, van Veldhuisen DJ. Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors. Drugs 2006; 66:2095-2107. (Pubitemid 46372360)
25. Shores MM, Pascualy M, Lewis NL, Flatness D, Veith RC. Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001; 26:433-439. (Pubitemid 32222947)
26. Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation 2008; 117:1991-1996. (Pubitemid 351543475)
27. Davies SJ, Ghahramani P, Jackson PR, Noble TW, Hardy PG, Hippisley-Cox J, Yeo WW, Ramsay LE. Association of panic disorder and panic attacks with hypertension. Am J Med 1999; 107:310-316. (Pubitemid 29465807)
28. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990; 147:1504-1508. (Pubitemid 20365441)
29. Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med 2002; 64:758-766.
30. Scherrer JF, Xian H, Bucholz KK, Eisen SA, Lyons MJ, Goldberg J, Tsuang M, True WR. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 2003; 65:548-557. (Pubitemid 36900249)
31. Shinn EH, Poston WS, Kimball KT, St Jeor ST, Foreyt JP. Blood pressure and symptoms of depression and anxiety: a prospective study. Am J Hypertens 2001; 14:660-664. (Pubitemid 32612530)
32. Yan LL, Liu K, Matthews KA, Daviglus ML, Ferguson TF, Kiefe CI. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA 2003; 290:2138-2148. (Pubitemid 37432974)
33. Barrett-Connor E, Palinkas LA. Low blood pressure and depression in older men: a population based study. BMJ 1994; 308:446-449. (Pubitemid 24084185)
34. Hildrum B, Mykletun A, Stordal E, Bjelland I, Dahl AA, Holmen J. Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study. J Epidemiol Community Health 2007; 61:53-58. (Pubitemid 46114590)
35. Hildrum B, Mykletun A, Holmen J, Dahl AA. Effect of anxiety and depression on blood pressure: 11-year longitudinal population study. Br J Psychiatry 2008; 193:108-113.
36. Paterniti S, Alpérovitch A, Ducimetière P, Dealberto MJ, Lépine JP, Bisserbe JC. Anxiety but not depression is associated with elevated blood pressure in a community group of French elderly. Psychosom Med 1999; 61: 77-83. (Pubitemid 29071849)